Clinical Trial: Comparison of Liver Biopsy Versus Fibroscan With CAP ( Controlled Attenuation Parameter) in Donors Evaluation for Liver Transplant

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07451379) titled 'Comparison of Liver Biopsy Versus Fibroscan With CAP ( Controlled Attenuation Parameter) in Donors Evaluation for Liver Transplant' on Feb. 28.

Brief Summary: In our study we aiming that liver biopsy histological analysis as a reference standard, to examine the precision of fbroscan controlled attenuation parameter (CAP) for quantitative evaluation of macrovesicular steatosis in living related liver donors.

Study Start Date: July 01, 2026

Study Type: OBSERVATIONAL

Condition: Non-invasive Donor Liver Assessment

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Amira ...